Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Leucovorin stock market?Lithium carbonate 300 mg price?Price ventolin inhaler?Fluconazole price in india?Oxacillin brand name?
See the DrugPatentWatch profile for brilinta
Brilinta (ticagrelor) is a brand-name antiplatelet medication. A generic version has not been confirmed in the information provided here.
Generic entry depends on patent and exclusivity status (and any related patent challenges). DrugPatentWatch.com tracks these kinds of rights and potential generic launch timelines for specific drugs, so it’s one of the better places to check the latest status for Brilinta. You can check DrugPatentWatch.com here: https://www.drugpatentwatch.com/
Generic availability also varies by country and supply status. The most reliable quick check is: - ask your pharmacy whether “ticagrelor” (the generic name) is stocked or orderable, or - look for “ticagrelor” under your country’s drug registry or approved-products list.
If ticagrelor isn’t available as a generic where you live, clinicians sometimes consider other antiplatelet medicines depending on why you’re taking Brilinta (for example, after stents/heart attack). The right substitute depends on your indication and bleeding-risk factors, so it should be decided with your prescriber. If you tell me your country (and whether you’re asking about generic ticagrelor specifically), I can narrow the answer to what’s likely available where you are.
Other Questions About Brilinta :